FDA approves Ritalin LA

The FDA granted marketing approval for Ritalin LA methylphenidate from Novartis (NVS; SWX:NOVN) to treat attention deficit hyperactivity disorder (ADHD). The once-daily formulation uses SODAS (spheroi...